Also affiliated with Peking University, First Affiliated Hospital of Jiangxi Medical College, Beijing Anzhen Hospital, Beijing Institute of Water, Peking University First Hospital, Wenzhou-Kean University, China Agricultural University, Hunan Agricultural University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Driven by 11 papers. Top paper: “Updated results of a phase IIa study to evaluate the clinical efficacy and safety of erdafitinib in Asian advanced cholangiocarcinoma (CCA) patients with FGFR alterations.”.
Yin-Hsun Feng, Yen-Yang Chen, Wu-Chou Su, Do-Youn Oh, Lin Shen +12 more
Gregory A Roth, Aleksandr Y Aravkin, Peng Zheng, Kalkidan Hassen Abate, Yohannes Habtegiorgis Abate +1790 more
Qimeng Wu, Sisi Yang, Yanjun Zhang, Chun Zhou, Mengyi Liu +10 more
Jing Nie, Rensheng Wang, Weidong Mao, Chang Liu
Sangita P. Patel, Jing Nie, Chris Andrews, Jean Wactawski‐Wende, Aladdin H. Shadyab +3 more
Jing Nie, Yihua Yue, Jean Wactawski‐Wende, Sangita P. Patel, Chris Andrews +4 more
Jing Nie, Anne Solbu, Maria Keller, Matthew Handmacher, Liise K. Kayler
Jing Nie, Yihua Yue, Chris Andrews, Jean Wactawski‐Wende, Robert B. Wallace +3 more
Jing Nie, Danielle R. Stevens, Jessica L. Gleason, Sandie Ha, Indulaxmi Seeni +3 more
Jing Nie, Maurizio Trevisan, Kristopher Attwood, Jo L. Freudenheim, Shipra Gandhi
Yingchu Dai, Wentao Hu, Yongsheng Zhang, Zhifei Cao, Weiwei Pei +10 more